ATH 25.0% 0.3¢ alterity therapeutics limited

Absurdity, page-8

  1. 46 Posts.
    Juno has plenty of money, raising nearly $700 million initially, with a prestigious lineage. Deals with big players all around. Did they get a free pass, a wink from the FDA? Did they get something that a small player with an address down under could never hope to get, or want to get? I'd settle for an objective safety review, which Prana certainly did not get.

    Check around, and I'll bet you there's some JUNO stock involved somewhere, somehow. Where's WikiLeaks when you need them.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.